The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma

Determination of hepatic galactose elimination capacity using 2-[18F]fluoro-2-deoxy-d-galactose PET/CT: reproducibility of the method and metabolic heterogeneity in a normal pig liver model

(2010) Michael Sørensen   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Evaluation of patients with hepatocellular carcinomas using [11C]acetate and [18F]FDG PET/CT: A preliminary study

(2009) Kyung Hoon Hwang et al.   APPLIED RADIATION AND ISOTOPES

Imaging of Proliferation in Hepatocellular Carcinoma with the In Vivo Marker 18F-Fluorothymidine

(2009) F. Eckel et al.   JOURNAL OF NUCLEAR MEDICINE

Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography

(2008) Michael Sørensen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Novel advancements in the management of hepatocellular carcinoma in 2008

(2008) Josep M. Llovet et al.   JOURNAL OF HEPATOLOGY

Detection of Hepatocellular Carcinoma Using 11C-Choline PET: Comparison with 18F-FDG PET

(2008) Y. Yamamoto et al.   JOURNAL OF NUCLEAR MEDICINE

A Prospective Evaluation of 18F-FDG and 11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma

(2008) J.-W. Park et al.   JOURNAL OF NUCLEAR MEDICINE

MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies

(2008) Jonathon M. Willatt et al.   RADIOLOGY